Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Cancer Vaccines

15 Sep 2014 - 16 Sep 2014 - London, UK



Bookmark and Share


Quantify Strategies to Enhance Cancer Vaccine Research and Development

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.

SMi Group have worked closely with an expert speaker panel which includes KOLs from Amal Therapeutics, Amgen, DanDrit Biotech, CureVac and Vaccinogen, to put together an exciting conference agenda for the 3rd annual conference taking place on 15th and 16th September in London UK.

This year's programme will feature a mix of case study led presentations, networking opportunities, an interactive workshop and keynote addresses that have been tailored for an audience of professionals working in the cancer vaccine market from drug design through to clinical trials and treatment.

Previous Testimonials Include:

"Great focused meeting. Good range of speakers and topics" – INSERM

"I found the conference very informative and the standard of the presentations was very good. I’m pleased that I attended" - Asterand

Key Speakers Include:

Joseph Melenhorst, Director of the Product Development & Correlative Sciences Laboratory, University Of Pennsylvania

Tom Lillie, Therapeutic Area Head, Oncology, Amgen Ltd

Alex Karlsson-Parra, CSO, Immunicum AB

Birgit Scheel, Director Program Management Oncology, Curevac GmbH

Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

Madiha Derouazi, CEO, Amal Therapeutics

Eric Leire, CEO, DanDrit Biotech

Why Attend in 2014?

Insight into a Perfect Partnership – University of Pennsylvania and Novartis Collaboration! Hear it here first: Assessing techniques involved in removing a patient's T cells and inserting new genetic material to enable the T cells to attack and kill cancer cells

Assessing Oncolytic Vaccines - Reviewing developments from Amgen and Psioxus Therapeutics

What are the key questions in Cancer Immunotherapy? Professor Christian Ottensmeier attacks this question head on!

Evaluating analytical advances for Cancer Vaccines with an insight from Key Opinion Leaders at Immatics GmbH, Vaccinogen and the University of Southampton

To register or download a brochure visit: 

http://www.smi-online.co.uk/goto/2014cancervaccinesevent24.asp 

For further details, contact Sajid Goraya on +44 (0)20 7827 6148 or email sgoraya@smi-online.co.uk 



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!